Switch to:
Progenics Pharmaceuticals, Inc. (NAS:PGNX)
Money Market Investments
$-65.86 Mil (As of Dec. 2013)

Progenics Pharmaceuticals, Inc.'s money market investment for the quarter that ended in Dec. 2013 was $-65.86 Mil. It means Progenics Pharmaceuticals, Inc. paid $65.86 Mil to invest on the money market.

Compared with last quarter ($-75.60 Mil in Sep. 2013 ), Progenics Pharmaceuticals, Inc. paid less money to invest on the money market in Dec. 2013 ($-65.86 Mil).


Definition

Money Market Investments carried on banks' balance sheet.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Progenics Pharmaceuticals, Inc. Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_MoneyMarket -5.23-67.07-11.95-10.42-56.19-90.90-47.92-70.11-58.84-65.86

Progenics Pharmaceuticals, Inc. Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
BS_MoneyMarket -78.00-70.11-56.10-47.82-41.10-58.84-55.28-79.22-75.60-65.86
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide